SCHEMBL742527

SCHEMBL742527

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccc(N4CCOCC4)cc3)n[nH]c2s1)c1ccccc1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 12/20 0.52
ABL1 P00519 1/20 0.50
BCR P11274 1/20 0.50
NTRK1 P04629 3/20 0.47
NTRK3 Q16288 2/20 0.47
NTRK2 Q16620 2/20 0.47
KIT P10721 2/20 0.45
FGFR1 P11362 2/20 0.45
KDR P35968 2/20 0.45
CDC7 O00311 1/20 0.45
CHEK1 O14757 1/20 0.45
JAK2 O60674 1/20 0.45
PAK4 O96013 1/20 0.45
PRKCB P05771 1/20 0.45
INSR P06213 1/20 0.45
RET P07949 1/20 0.45
PRKACA P17612 1/20 0.45
FLT4 P35916 1/20 0.45
JAK3 P52333 1/20 0.45
PDK1 Q15118 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL742121 0.92 AURKA (0.62) AURKAABL1BCRNTRK1KIT
SCHEMBL741251 0.90 AURKA (0.64) AURKAABL1BCRNTRK1KIT
SCHEMBL2432386 0.89 AURKA (0.47) AURKAABL1BCRNTRK1NTRK3
SCHEMBL740144 0.89 ABL1 (0.52) AURKAABL1BCRKDRFLT3
SCHEMBL742155 0.89 FGFR1 (0.51) AURKAABL1BCRNTRK1KIT
SCHEMBL740120 0.89 AURKA (0.55) AURKAABL1BCRNTRK1NTRK3
SCHEMBL741174 0.88 AURKA (0.54) AURKAABL1BCRNTRK1NTRK3
SCHEMBL740826 0.85 AURKA (0.55) AURKAABL1BCRNTRK1KIT
SCHEMBL740681 0.84 AURKA (0.54) AURKAABL1BCRNTRK1KIT
SCHEMBL739540 0.84 AURKA (0.54) AURKAABL1BCRNTRK1KIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
EP-2007380-B1 USE OF A KINASE INHIBITOR FOR THE TREATMENT OF PARTICULAR RESISTANT TUMORS NERVIANO MEDICAL SCIENCES SRL (IT) 2011-09-14 EP claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed